Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement
Scinai Immunotherapeutics announced a $4.0 million financing combining a private placement of 2,458,334 ADSs with Series A-1 warrants and a warrant inducement at $1.20 per ADS. An existing life sciences institutional investor will immediately exercise April 2026 warrants on 879,194 ADSs at the reduced $1.20 price in exchange for new five-year warrants on up to 1,318,791 additional ADSs. Proceeds will fund CDMO expansion, customer programs, and selective pipeline investment; A.G.P./Alliance Global Partners is sole placement agent.
Key figures
- Deal Value Usd
- 4000000
- Offering Price
- 1.2
- Shares Offered
- 2,458,334 ADSs plus Series A-1 warrants on up to 3,687,501 ADSs and 1,318,791 ADSs (New Warrants); Existing Warrants on 879,194 ADSs exercised
- Warrant term
- 5 years
- New warrant ads
- 1318791
- Warrant exercise price
- $1.20 per ADS
- Existing warrants exercised ads
- 879194
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.